The nuclear receptor PPAR-γ has the inherent capacity to regulate expression of macrophage chemokine receptors (CX3CR1 and CCR2) in lipid-mediated inflammation in atherosclerosis lesions [21], [22]. Here, PPARG is linked to atherosclerosis.